The longevity transporter mIndy (Slc13a5) as a target for treating hepatic steatosis and insulin resistance.

导出 OA

翻译打印收藏纠错

作者： Diana M,Willmes ^[1] ; Stephen L,Helfand ^[2] ; Andreas L,Birkenfeld ^[3]

作者单位： Section of Metabolic Vascular Medicine, Medical Clinic III, Dresden University School of Medicine, Technische Universität Dresden, Dresden, Germany. ^[1] Paul Langerhans Institute Dresden (PLID), German Center for Diabetes Research (DZD), Dresden, Germany. ^[2] Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02912, USA. ^[3]

关键词 INDY Slc13a5 aging fatty liver longevity type 2 diabetes

主题词动物(Animals);脂肪肝(Fatty Liver);人类(Humans);胰岛素抗药性(Insulin Resistance);长寿(Longevity);协同转运子(Symporters)

DOI 10.18632/aging.100907

PMID 26928109

发布时间 2019-10-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交